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The p21-activated kinase (PAK) proteins regulate many cellular events including cell cycle progression, cell death and survival, and
cytoskeleton rearrangements. We previously identified X-PAK5 that binds the actin and microtubule networks, and could potentially regulate
their coordinated dynamics during cell motility. In this study, we investigated the functional importance of this kinase during gastrulation in
Xenopus. X-PAK5 is mainly expressed in regions of the embryo that undergo extensive cell movements during gastrula such as the animal
hemisphere and the marginal zone. Expression of a kinase-dead mutant inhibits convergent extension movements in whole embryos and in
activin-treated animal cap by modifying behavior of cells. This phenotype is rescued in embryo by adding back X-PAK5 catalytic activity.
The active kinase decreases cell adhesiveness when expressed in animal hemisphere and inhibits the calcium-dependent reassociation of
cells, while dead X-PAK5 kinase localizes to cell–cell junctions and increases cell adhesion. In addition, endogenous X-PAK5 colocalizes
with adherens junction proteins and its activity is regulated by extracellular calcium. Taken together, our results suggest that X-PAK5
regulates convergent extension movements in vivo by modulating the calcium-mediated cell–cell adhesion.
D 2004 Elsevier Inc. All rights reserved.
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During gastrulation, germ layers undergo temporally and
spatially coordinated movements that bring progenitor cells
into positions from which they later form tissues and organs.
In Xenopus, convergence extension (CE) movements are
essential early during development for the formation and the
elongation of the body axis. During CE movements, cells of
the marginal zone polarize, elongate, and align before they
intercalate between one another (Keller et al., 2000; Shih
and Keller, 1992). These lateral cell movements result in the0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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lengthening (extension) of the embryo.
In Xenopus embryo, Wnt signaling is best known as a
regulator of dorsal cell fate through a T canonical r h-
catenin pathway. Wnt also tightly regulates CE movements
through activation of two T noncanonical r pathways that
respond to members of Wnt superfamily ligands such as
Wnt-5a and Wnt-11 (Tada and Smith, 2000; Torres et al.,
1996). These ligands, respectively, turn on the Wnt/Ca2+
and the Wnt/JNK pathways (the vertebrate equivalent to the
planar cell polarity or PCP pathway in Drosophila) (for
review, see Kuhl, 2002; Tada et al., 2002; Wallingford et
al., 2002) that act as antagonists of the Wnt/h-catenin
signaling (for review, see Weidinger and Moon, 2003). In
response to noncanonical Wnt signaling, cells eventually
develop the capacity to change their shape, their polarity,277 (2005) 472–492
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to occur.
Indeed, the family of Rho GTPases that controls
cytoskeleton reorganization and cell adhesion (for review,
see Hall and Nobes, 2000; Jaffer and Chernoff, 2004;
Kaibuchi et al., 1999; Schmitz et al., 2000) is also essential
for regulating CE movements in Xenopus embryo. Inacti-
vation of either endogenous Rac, Cdc42, or RhoA prevents
CE movements to occur (Choi and Han, 2002; Habas et al.,
2001, 2003; Tahinci and Symes, 2003). Both RhoA and Rac
are effectors of the PCP pathway (Habas et al., 2001, 2003)
although their activation is not dependent upon each other
(Habas et al., 2003). Cdc42 is involved in Wnt/Ca2+
signaling and regulates CE movements downstream of
Ghg (Penzo-Mendez et al., 2003) and PKC (Choi and
Han, 2002; Penzo-Mendez et al., 2003). While clearly
GTPases are involved in CE, the GTPase effectors that
regulate changes in polarity, protrusive, and adhesive
activities of cells during CE are not well characterized.
Changes in polarity and directional movements could
involve effectors that capture and stabilize microtubules
near the cell cortex such as IQGAP1 and Par6 downstream of
Cdc42 or mDia downstream of RhoA (Etienne-Manneville
and Hall, 2001; Fukata et al., 2002; Palazzo et al., 2001).
Changes in adhesive properties, morphology, protrusive
activity, and generation of forces for cell translocation and
movements involve reorganization of the actin cytoskeleton
and the adherence junctions. A number of GTPase effectors
downstream of Rac and Cdc42 could be involved. p21-
activated kinases (PAKs) are good candidates for this role
since they have been shown to control cell shape and motility
(for review, see Bokoch, 2003; Jaffer and Chernoff, 2002).
PAK subgroups I and II are distinguished based upon their
structural organization and regulation. Binding of GTP-
bound Rac or Cdc42 to subgroup I PAKs (PAK1–3) causes
the dissociation of the PAK kinase autoinhibitory domain
(AID) and the C-terminal catalytic domain, thus allowing
autophosphorylation and full activation of the kinase
(Buchwald et al., 2001; Chong et al., 2001; Lei et al.,
2000). In contrast, subgroup II PAKs (PAK4–6) appear to
lack a classic AID and are not directly activated by binding
of active Rac and Cdc42 GTPases. Both subgroup kinases
are involved in the regulation of MAP kinase cascades, cell
cycle, and apoptosis (for review, see Bokoch, 2003; Jaffer
and Chernoff, 2002), and were shown to regulate cell
cytoskeletal changes. Individual PAKs act through a number
of targets including the myosin light chain kinase (MLCK)
(Sanders et al., 1999), regulatory myosin light chain
(Goeckeler et al., 2000), Caldesmon (Foster et al., 2000),
filamin (Vadlamudi et al., 2002), desmin (Ohtakara et al.,
2000), Lim kinase (Dan et al., 2001; Edwards et al., 1999),
and integrin alpha v beta 5 (Zhang et al., 2002). Subgroup I
and II PAKs may carry out different functions in a same cell
as highlighted in Schneeberger and Raabe (2003). In
developing photoreceptor cells, Drosophila subgroup II
PAK Mbt depends upon Cdc42 binding for its localizationto adherence junctions (Schneeberger and Raabe, 2003) and
is required for cell morphogenesis, while DPAK, a subgroup
I PAK, is required in growth cones to control axon guidance
(Hing et al., 1999).
Human PAK4, a member of subgroup II, induces loss of
cell adhesion and anchorage-independent growth that
characterize oncogenic cell transformation (Callow et al.,
2002; Qu et al., 2001). We previously described a subgroup
II Xenopus PAK, X-PAK5, that is closely related to hPAK4.
X-PAK5 binds the actin and microtubule networks (Cau et
al., 2001), and binding of active GTPases to the endogenous
kinase induces its relocalization to actin-rich structures.
Both the actin and microtubule networks are important in
the regulation of cell motility. This led us to investigate
whether X-PAK5 may regulate the extensive cell rearrange-
ments that occur during gastrulation in Xenopus. In this
report, we show that X-PAK5, which is expressed during
early development, is present in regions where morphoge-
netic movements are induced at the onset of gastrulation.
Expression of kinase-dead mutant impairs CE movements
and results in defects in blastopore closure. Kinase-dead
mutants act at least by strengthening cell–cell junctions in
embryonic cells while active X-PAK5 changes the adhesive
properties of cells. Changes in cell adhesion eventually lead
to embryos that develop tissue protrusions. Finally, our data
indicate that the catalytic activity of X-PAK5 is regulated
upon calcium-induced aggregation of dissociated cells. We
finally show that endogenous, active, and dead-kinase
mutants of X-PAK5 colocalize at least partially with
adherens junction proteins.Materials and methods
Embryo manipulation
Eggs were collected from Xenopus females and artifi-
cially fertilized as previously described (Watanabe and
Whitman, 1999). Embryos were dejellied before the first
cleavage in 3% cysteine and injected in 3% Ficoll in
0.1 Marc’s modified Ringer medium (MMR). Embryos
were staged according to Nieuwkoop and Faber (1967).
Animal caps were dissected at stage 8.5 and incubated in
0.7 MMR in the presence or absence of partially purified
human activin A at a final concentration of 8 units/ml
(Cooke et al., 1987) (kindly provided by J.C. Smith).
Animal caps were cultured to stage 18 equivalent. Cyclo-
heximide treatment was performed by transferring embryos
to 0.1 mg/ml cycloheximide in 0.7 MMR.
Anti-X-PAK antibodies
The polyclonal anti-X-PAK5 antibodies have been raised
against the unique 122–224 amino acids of X-PAK5 (Cau et
al., 2001). Immunopurified antibodies specifically detect a
single band of 75 kDa in Xenopus eggs and embryos.
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Technology) were made against a phospho-peptide sur-
rounding the Serine 533 (Ser533) in X-PAK5 equivalent to
the Ser474 in hPAK4, the Ser602 in hPAK5, and the Ser560
in hPAK6, in the catalytic loop of the kinase. Phosphor-
ylation at this site was previously shown to be required for
full activation of subgroup II PAK kinases (Gnesutta et al.,
2001), and these antibodies recognize the activated forms of
human PAK4, PAK5, and PAK6 (data not shown). Their
characterization in Xenopus is presented in Supplementary
Fig. S1. Anti-PhosphoPAK4/PAK5/PAK6 antibodies specif-
ically detect autophosphorylated active X-PAK5 kinase and
do not cross react with the nonactive form of the kinase. In
some Western blot analyses, a second species migrating
around 115–120 kDa was recognized as well, preventing the
use of these antibodies in immunohistochemistry analyses.
However, as X-PAK5 is the only Xenopus PAK kinase of
the subgroup II identified so far and because X-PAK5 is the
major endogenous protein detected in Xenopus embryo, we
will refer for simplicity to the endogenous PhosphoPAK4/
PAK5/PAK6 signal detected in Xenopus embryos as
phosphoPAK5 signal even though other X-PAKs from
subgroup II may also be detected by these antibodies.
Xenopus X-PAK2 polyclonal antibodies have been raised by
immunization of rabbits with the recombinant N-terminal
domain of X-PAK2 (amino acids 2–214) in fusion with the
MBP and immunopurified by using the corresponding
recombinant protein (Cau et al., 2000).
Western blot analyses, immunoprecipitations, and kinase
assays
Western blot analyses were performed essentially as
previously described (Faure et al., 2000). Whole embryos or
animal caps were homogenized (10 Al per embryo and 10 Al
for 10 caps) in lysis buffer (20 mM Tris pH 8, 50 mM NaCl,
50 mM NaF, 10 mM hglycerophosphate, 2 mM EDTA, 1%
NP 40, 20 mM aprotinin, 0.75 mM PMSF). Lysates were
centrifuged at 14,000  g for 10 min at 48C; supernatants
were analyzed on 10% SDS-polyacrylamide gels (SDS-
PAGE) and transferred to nitrocellulose (Protran). Mem-
branes were blocked at room temperature for 1 h in 2% milk
in TBST (10 mM Tris pH 8, 150 mM NaCl, 0.2% Tween
20) and incubated overnight at 48C with either immuno-
purified anti-X-PAK5 antibody (abn122) or anti-X-PAK2
antibody (Cau et al., 2000, 2001) or anti-PhosphoPAK4/5/6
antibodies (Cell Signalling Technology) or anti-h tubulin
(clone E7, Developmental Studies Hybridoma Bank,
DSHB, University of Iowa) or anti-g tubulin antibody
(SIGMA). After several washes in TBST, membranes were
incubated for 1 h at room temperature with peroxidase-
conjugated secondary antibody (Amersham Biosciences),
washed in TBST, and developed with cheminumilescence
reagents (Perkin-Elmer, Life Sciences) as described by the
manufacturer. Immunoprecipitation experiments were per-
formed essentially as previously described (Cau et al.,2000). One equivalent embryo lysate was diluted in TLB
buffer (20 mM Tris pH 7.5, 137 mM NaCl, 2 mM EDTA,
1% Triton X-100, 10% glycerol, 2 mM orthovanadate) and
incubated for 2 h with the immunopurified anti-X-PAK5
antibody (abn122). For kinase assays, immunoprecipitates
were washed twice in TLB buffer and twice in kinase buffer
(25 mM HEPES, pH 7.5, 25 mM MgCl2, 25 mM
hglycerophosphate, 2 mM DTT, 0.1 mM orthovanadate)
and then incubated for 15 min in 20 Al of kinase buffer
containing 2 Al of histone H2B at 5 mg/ml, 1 mM ATP, and
0.5 Al of g-32P(ATP) (3000 Ci/mmol). Immunoprecipitates
were subjected to 20% SDS-PAGE and phosphorylated-
histone H2B visualized by autoradiography.
Immunohistochemistry and immunofluorescence analyses
Xenopus embryos were fixed in MEMFA (0.1 M MOPS
pH 7.4, 2 mM EGTA pH 8, 1 mM MgSO4, 3.7%
formaldehyde) for 2 h at room temperature and analyzed
by immunochemistry analysis as previously described
(Faure et al., 2000). Incubation with the immunopurified
anti-X-PAK5 antibody (abn122) at a dilution of 1/100 in
TBST was carried out overnight at 48C. After several
washes, embryos were incubated with peroxidase-conju-
gated secondary antibody (Amersham Biosciences). Signal
was detected by using the Fast 3,3’-Diaminobenzidine
Tablet sets (SIGMA). For confocal analyses, uninjected
animal cap explants were dissected at stage 8 and fixed in
2% paraformaldehyde in phosphate-buffered saline (PBS)
for 2 h at room temperature. After fixation, explants were
incubated overnight with anti-X-PAK5 antibody (abn122) in
PBS supplemented with 0.05% Triton X-100 and 5% fetal
calf serum (PBSTF). After washes with several batches of
TBSTF, explants were incubated with anti-rabbit antibodies
linked to Alexa 670 (Molecular Probes) and observed with
LSM510Meta confocal microscope. Alternatively, cap
explants dissected from GFP-X-PAK5-injected embryos
were mounted in dissection buffer and immediately
observed after dissection to avoid diffusion of the gfp signal.
Epithelial Xenopus A6 cells were used for transfection
experiments. Cells were transfected for 24 h by either GFP-
X-PAK5 K/R or GFP-X-PAK5/EN mutants in pCS2+
vector using Fugene reagent (Roche) following the manu-
facturer’s recommendations. Transfected and mock-trans-
fected cells were fixed with 100% methanol for 8 min at
208C, incubated with either E-cadherin (clone 5D3,
Developmental Studies Hybridoma Bank, DSHB, univer-
sity of Iowa) or g-catenin (BD transduction laboratories)
monoclonal antibodies. In addition, mock-transfected cells
were incubated with Abn122. Primary antibodies were used
for 1 h at room temperature in PBSTF, then cells were
extensively washed in PBSTF and incubated with anti-
mouse Alexa 555 and anti-rabbit Alexa 670 (Molecular
Probes). Following extensive washes in PBSTF, cells were
mounted in Vectashield and observed with LSM510Meta
confocal microscope.
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h-Galactosidase (h-gal) staining was carried out essen-
tially as described (Tada et al., 1997). Embryos were fixed
in MEMFA at 48C for 2 h. Then, they were washed in PBS
containing 0.02% NP 40 and stained at 208C in a PBS
solution containing 1 mg/ml X-gal, 5 mM K3Fe(CN)6, 5
Mm k4Fe(CN)6, 2 mM MgCl2, and 0.02% NP 40.
In vitro transcription
We previously isolated the full-length X-PAK5 cDNA
and subcloned it in pEGFP vector (Cau et al., 2001). The
cDNA encoding for a GFP-X-PAK5 fusion was subcloned in
pCS2 + vector. X-PAK5 K/R, X-PAK5S533A, and X-PAK5/
EN mutants were constructed by site-directed mutagenesis.
The following changes were made: K to R at residue 409
located in the putative ATP binding site for X-PAK5 K/R, S
to A at residue 533 in the activation loop of X-PAK5 kinase
for X-PAK5S533A. When expressed either in cells or in
embryos, both X-PAK5 K/R and X-PAK5S533A mutants
display no kinase activity. For X-PAK5/EN mutant, serine
residues at position 504 and 533 have been substituted,
respectively, by E and N (Cau et al., 2001). All mutations
were verified by sequencing. The pCS2 X-PAK5 constructs
were linearized with Nsi1 restriction enzyme for in vitro
transcription. Capped-synthetic mRNAs were generated
with SP6 polymerase by using the mMessage mMachine
kit (Ambion) as described by the manufacturer.
In situ hybridization
Whole-mount in situ hybridization was performed
essentially as described (Harland, 1991). XBrachyury
(Xbra), Goosecoid (gsc) (Cho et al., 1991; Smith et al.,
1991), and Xotx-2 (Pannese et al., 1995) probes were kindly
provided by Dr. J. C. Smith, and Xnot probe (Hoppler and
Moon, 1998; von Dassow et al., 1993) by Dr. R. Moon.
Cell adhesion assay
Cell adhesion assay was carried out as previously
described (Choi and Han, 2002). Briefly, embryos were
injected at two-cell stage into the animal pole; animal caps
were dissected at stage 8.5 and dissociated in Ca2+/Mg2+-
free medium (CMFM) (88 mM NaCl, 1 mM KCl, 2.4 mM
NaHCO3, 7.5 mM Tris pH 7.6) until dissociation was
complete. Dissociated cells were reaggregated at 208C in
CMFM plus 4 mM Ca2+ with gentle shaking and then fixed
in MEMFA at the indicated time.
Procaspase 3 cleavage assay
The procaspase 3 cleavage assay was performed essen-
tially as described by Hensey and Gautier (1997). Briefly,
five embryos were homogenized in EB buffer (80 mM h-glycerophosphate pH 7.3, 15 mM MgCl2, 20 mM EGTA, 10
mM DTT plus protease inhibitors). Homogenates were
centrifuged at 14,000  g for 10 min at 48C. Three
microliters of supernatant was mixed with 1 Al of
(35S)methionine-labeled mammalian procaspase 3 and incu-
bated at room temperature for 20 min. Samples were run on a
15% SDS-PAGE gel and transferred to nitrocellulose
(Protran). Cleavage of procaspase 3 was visualized by
autoradiography. In vitro translation of pcDNA3 procaspase
3 was performed as previously reported (Faure et al., 1997).Results
Spatiotemporal expression pattern of X-PAK5 during early
Xenopus development
We first examined the temporal expression pattern of X-
PAK5 during early Xenopus embryogenesis by Western blot
analysis using specific antibodies to X-PAK5 (Cau et al.,
2001). X-PAK5 is expressed from maternal mRNAs up to
midblastula transition (MBT) (Fig. 1A, upper panel). Levels
of X-PAK5 expression increase during the course of
gastrulation when zygotic expression starts (between stages
9 and 10) (Fig. 1A, bottom panel) and becomes constant
later in development. This pattern is specific to X-PAK5 as
expression of X-PAK2, another X-PAK member, is constant
throughout early embryogenesis (Fig. 1A).
We then examined the localization of X-PAK5 across the
animal–vegetal axis. We dissected animal (A), marginal (M),
and vegetal (V) regions from whole embryos at early gastrula
stage and extracts were analyzed by Western blot using X-
PAK5 antibodies as in Fig. 1A. With respect to the h-tubulin
Western blot control (see legend of the figure), stage 10
animal and marginal explants contain similar levels of X-
PAK5 while its expression level is lower in the vegetal region
(Fig. 1B). By contrast, X-PAK2 expression level is similar in
the three different dissected regions of the embryos.
We then visualized the localization of X-PAK5 during
gastrulation by immunochemistry analysis (Fig. 1C). At the
onset of gastrulation (stages 10+ and 10.25), X-PAK5
expression is essentially located in the animal pole and the
marginal zone as previously shown by Western blot analysis
(Fig. 1B). In the marginal zone, the X-PAK5 signal is
detected in mesodermal-fated cells that migrate inwards the
embryo. Later during gastrulation (stage 11.5), X-PAK5
expression is detected in the ectoderm and in involuting
dorsal and ventral mesoderm. Taken together, our results
indicate that the X-PAK5 protein is expressed primarily in
the cells of both the animal hemisphere and the marginal
zone where extensive cell rearrangements take place during
gastrula.
We further analyzed the localization of X-PAK5 in
embryonic cells from animal cap explants dissected at stage
8 and from dorsal marginal zone (DMZ) explants dissected
at stage 10.25 using a confocal microscope (Fig. 1D). In
Fig. 1. Spatiotemporal expression pattern of X-PAK5 during early Xenopus development. (A) Temporal expression pattern of X-PAK5. Protein extracts from
embryos harvested at the indicated stages were subjected to Western blot analyses with anti-X-PAK5, anti-X-PAK2, and anti-g tubulin antibodies. Levels of
g-tubulin reflect proteins loading. (Upper panel) Temporal expression pattern of X-PAK5 during early development (from stage 5 to stage 24). (Bottom panel)
Temporal expression pattern of X-PAK5 from blastula to gastrula. Level of X-PAK5 increases during the course of gastrulation when zygotic expression starts
and levels remain constant from stage 10 until at least stage 24. In control, temporal expression of X-PAK2 is shown. Note that X-PAK2 antibodies reveal a
doublet in embryonic lysates and the signal associated with the bottom band increases during the course of development. The same pattern is observed during
early development if antibodies directed against the C-terminal region of X-PAK2 are used for Western blot detection suggesting that the bottom band is not a
proteolytic product of X-PAK2. This lower band is not detected in Xenopus oocytes (Cau et al., 2000). However, it is repeatedly detected around stage 9 during
development and is likely due to either a posttranslational modification of X-PAK2 or to the expression of a zygotic closely related X-PAK2 isoform whose
expression increases after MBT. MBT, midblastula transition. (B) Spatial distribution of X-PAK5 across the animal–vegetal axis. Xenopus embryos were
dissected at stage 10+ into animal poles (A), equatorial marginal zones (M), and vegetal regions (V). Control whole embryos (We) were harvested at the same
stage and embryonic lysates performed. Since cell size varies greatly across the animal–vegetal axis, protein extracts were standardized by Western blot analysis
using h-tubulin as a loading control for cellular volume. Western blot analyses of similar volumes of dissected pieces and whole embryos (with respect to the
h-tubulin control) are shown. X-PAK5 protein is mainly localized in the animal pole and the equatorial marginal zone in the early gastrula embryo. (C)
Immunostaining of X-PAK5 across the dorsoventral axis. Xenopus embryos were fixed in MEMFA at the onset of gastrula (stage 10+), at midgastrula (stage
10.25), and late gastrula (stage 11.5), and bisected along the dorsoventral axis for immunohistochemistry. Dorsoventral orientation was determined by the dorsal
blastopore lip. X-PAK5 expression is essentially located in the ectoderm and in marginal zone cells including the mesodermal-fated cells that migrate inwards the
embryo. Some staining was also detected in nuclei of endodermal cells. No significant signal was detected in immunohistochemical control detection when
primary antibody addition was omitted. (D) Subcellular localization of endogenous X-PAK5 in animal explants (dissected at stage 8) and dorsal marginal zone
(DMZ) explants (dissected at stage 10.25) using anti-PAK5 Abn122. Immunodetection of g-catenin on cap explants serves as a control for cell–cell junction
staining. Abbreviations: mdm, migrating dorsal mesoderm; dbl, dorsal blastopore lip; ivm, involuting ventral mesoderm; idm, involuting dorsal mesoderm.
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detected, but the endogenous kinase is mainly localized to
the cytoplasmic membrane and at cell–cell junctions where
it partially colocalizes with g catenin, an adherens junction
and desmosome protein component (Ben-Ze’ev and Geiger,
1998). Occasionally, some staining is detected in nuclei as
well (data not shown). In DMZ cells, X-PAK5 is also
localized at cell–cell junctions and some nuclear and
cytoplasmic staining is also detected.
Expression of a kinase-dead mutant of X-PAK5 affects CE
movements during gastrulation
We showed that X-PAK5 is expressed during early
development both when and where extensive cell move-
ments take place (Fig. 1). In order to study the role of
X-PAK5 during early development, we attempted to
deplete X-PAK5 via a morpholino antisense oligonucleo-
tide (MO). However, injection of the X-PAK5 MO failed
to reduce X-PAK5 protein level (data not shown). To
alleviate this problem, we took advantage of a full-length
kinase-dead X-PAK5 mutant in fusion with the green
fluorescent protein (GFP-X-PAK5 K/R) (Cau et al., 2001)
that we will refer in the text as X-PAK5 K/R for
simplicity. Injection of X-PAK5 K/R mRNA in the DMZ
of four-cell stage embryos induces profound developmental
defects in a dose-dependent manner whereas the develop-
ment of gfp-injected control embryos is normal. At high
doses (500–900 pg mRNAs injected per embryo), X-PAK5
K/R expression causes strong developmental defects that
are clearly seen at stage 6–7 around the presumptive
injection site. The majority of these embryos does not
survive beyond stages 10–11. Indeed, the injected cells
appear both larger than their noninjected neighboring cells
and delayed in their division (data not shown).
Subsequently, in this study, we always used lower doses
of mRNAs (100–400 pg per embryo). The expression level
of the injected X-PAK5 K/R mutant is shown in Fig. 2B.
Under these conditions, most of the X-PAK5 K/R-injected
embryos examined at stage 35 develop dorsal defects that are
characterized by a shortened anteroposterior axis, a strong
dorsal flexure compared to gfp-injected embryos (Fig. 2A,
compare panel a to b), and, in some cases, an open neural
tube (see arrow in Fig. 2A, panel c). As such a phenotype
may result from defects in cell movements early during
gastrulation, we analyzed the effect of X-PAK5 K/R
expression at earlier stages during development (Fig. 2C
and Table 1). During early development, X-PAK5 K/R-
injected embryos appear normal as they form the dorsal
blastopore lip at the same time as the sibling embryos (data
not shown). However, at stage 11, by the end of gastrulation,
80% (n = 75) of X-PAK5 K/R-injected embryos display a
large-sized blastopore compared to controls (Fig. 2C,
compare panels a and b) that will eventually raise two
phenotypes. The most severe phenotype is characterized by
an opened blastopore at stage 12 by comparison withcontrols (Fig. 2C, compare panels c and d). When they
reach neurula stages, these embryos present a mass of
noninternalized yolk resulting from a defect in mesoderm
involution during gastrulation (Fig. 2C, compare panels e
and g to f and h). Finally, these embryos will develop in 39%
of cases (n = 75) a strong dorsal flexure and an open neural
tube as shown previously (Fig. 2A, panel c). In the less
severe phenotype, the closure of the blastopore is delayed
and the neural folds fail to fuse correctly; at neurula stages,
these embryos will develop in 46% of cases (n = 75) the bent
axis shown in Fig. 2A (panel b).
These results indicate that expression of X-PAK5 K/R is
likely to interfere with cells movements that occur during
gastrulation. In order to confirm this hypothesis, we
analyzed over time the behavior and localization of cells
that express gfp control or X-PAK5 K/R proteins by
following the gfp fluorescent emission of injected living
embryos. Prior to the onset of cell movements in early
gastrulae, fluorescent cells are located at the level of
injection site in the DMZ both in gfp and in X-PAK5 K/
R-injected embryos (data not shown). In stage 12 control
embryos, the gfp-injected cells have moved toward the
midline of the embryo as a result of cell intercalation; they
are positioned from the DMZ, the site of injection, to the
blastopore lip through which they are moving inside the
embryo (Fig. 2C, panel i). However, in X-PAK5 K/R-
injected embryos at stage 12 equivalent, expressing cells
remain clustered at the level of the injection site in the
DMZ; they do not rearrange into the rod-like structure
observed in controls, indicating that they fail to intercalate
(Fig. 2C, panel j). This is confirmed by gfp stainings later in
development at neurula stage (Fig. 2C, compare panels k to
l). Thus, these results further indicate that CE movements
are impaired in X-PAK5 K/R-injected embryos. To confirm
that X-PAK5 functions in regulating CE, we used the animal
cap assay. This assay is widely used since it mimics in vitro
the CE movements that take place in vivo (Symes and
Smith, 1987). Gfp and X-PAK5 K/R mRNAs were micro-
injected in the animal pole of two-cell stage embryos and
animal cap dissected at blastula stage (stage 8.5). Explants
were then cultured in the presence or absence of activin until
stage 18 equivalent (Fig. 2D). In the absence of activin
treatment, both gfp control and X-PAK5 K/R caps form
tight balls of cells. As expected, in response to activin, caps
of gfp-injected embryos elongate. In contrast, expression of
X-PAK5 K/R strongly inhibits the elongation of animal
explants induced by activin. Taken together, our results
show that expression of a kinase-dead mutant of X-PAK5
inhibits CE movements that take place during gastrulation in
whole embryo and in activin-treated animal caps.
Expression of X-PAK5 K/R affects CE movements during
gastrulation without preventing mesoderm specification
X-PAK5 K/R could affect CE movements either by
acting directly on cell shape and migratory behavior or
S. Faure et al. / Developmental Biology 277 (2005) 472–492478alternatively by modifying tissue-specific gene expression.
In order to distinguish between these two possibilities, we
analyzed by in situ hybridization the expression pattern of
the mesodermal markers Brachyury (Xbra), Goosecoid(Xgsc), Xotx-2, and Xnot. During early development, these
markers are all expressed in cells that undergo CE move-
ments and that will form the axial mesoderm. If X-PAK5
directly regulates cell movements, expression of X-PAK5
Table 1
Effects of X-PAK5 K/R overexpression on blastopore closure and early
development
mRNA injected n Blastopore Late phenotypes
Normal Open Normal Open
neural
tube
bent
axis
Gfp 70 93 7 91 3 6
X-PAK5 K/R 75 20 80 15 39 46
Embryos were injected at four-cell stage in the DMZ with indicated
mRNAs. Blastopore closure and late phenotypes were scored at stage 13
and 23, respectively. Numbers refer to percentages of phenotypes, n refers
to the total number of embryos analyzed.
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specification of tissues. Early during gastrulation, Xgsc is
expressed in the deep layer of the upper part of the dorsal
blastopore lip and later restricted to the notochord and
prechordal mesoderm (Cho et al., 1991). Xotx-2 expression
is first detected in migratory deep zone cells that are fated to
give rise to prechordal mesoderm and later in the
presumptive anterior neuroectoderm (Pannese et al.,
1995). During gastrulation, Xbra is first detected in the
entire marginal zone and later becomes restricted to the
blastopore and the developing notochord (Smith et al.,
1991). It was reported that interfering with receptor tyrosine
kinase (RTK) signaling that regulates mesoderm specifica-
tion prevents Xbra expression (Amaya et al., 1993; Myers et
al., 2004). Here, we show that interfering with X-PAK5
signaling does not affect Xbra expression level at the onset
of gastrulation, as similar levels of Xbra are detected in
X-PAK5 K/R-injected and control embryos (Fig. 3A).
Furthermore, at stage 10+, Xgsc and Xotx-2 are identically
expressed in X-PAK5 K/R and control embryos as well (Fig.
3B and data not shown). Altogether, our results show that
X-PAK5 K/R expression does not interfere with the
expression of mesodermal markers. However, as develop-
ment proceeds to late gastrula/early neurula stages, the
distribution of mRNAs coding for these mesodermal genes
is affected in X-PAK5 K/R-injected embryos consistent with
a role of X-PAK5 K/R in modifying the behavior of DMZFig. 2. Ectopic expression of X-PAK5 K/R affects gastrulation movements. (A–C)
mRNA or with 300 pg of GFP-X-PAK5 K/R mRNA and examined during their
embryos at stage 35. (b–c) GFP-X-PAK5 K/R-injected embryos at stage 35 equival
severe phenotype (c), the neural tube remains opened as indicated by a black arrow
(B) Analyses of expression level of GFP-X-PAK5 K/R mutant in Xenopus embryos
GFP-X-PAK5 K/R-injected embryos harvested at stage 12. Endogenous X-PAK5 p
K/R mutant migrates around 110 kDa (see black arrow). (C) Representative samp
GFP control (Ctrl) embryos. (b, d, f, and h) GFP-X-PAK5 K/R-injected embryos. (
25. White arrow in panel h indicates the presence of visible mass of endoderm th
convergence extension movements in gfp control and GFP-X-PAK5 KR-injected
stage 12. (j) GFP-X-PAK5 KR-injected embryo at stage 12 equivalent. The CE m
stage 20. (l) In stage 20 GFP-X-PAK5 KR-injected embryos, the labeled mesod
embryos are indicated in k and l. (D) Animal cap assay. Two-cell stage embryos we
with GFP-X-PAK5 mRNA (300 pg per embryo). Animal cap explants were exc
(activin) of recombinant activin. In response to activin, animal cap explants
GFP-X-PAK5 K/R inhibits their elongation.cells. At stage 11.5, the expression domain of Xbra is
broader around the blastopore but reduced in notochordal
mesodermal cells (see black arrow in Fig. 3C), indicating
that mesodermal cells failed to involute properly during
gastrulation. A similar distribution of Xbra staining at stage
12 was previously observed in embryos expressing mutants
of CDC42 and Xfz7 in which CE movements are impaired
(Choi and Han, 2002; Djiane et al., 2000). At stage 12, Xgsc
expression is localized at the dorsal blastopore lip and in the
anterior region of the embryo (arrows in Fig. 3D) while its
expression is restricted to the anterior embryonic domain in
controls. Expression of Xotx-2 in X-PAK5 K/R-injected late
gastrulae (stage 12.5) is detected in a broad domain that
extends more dorsovegetally than in control embryos (Fig.
3E). In some X-PAK5 K/R-injected embryos, expression of
Xotx-2 is also detected near the blastopore lip (see arrows in
Fig. 3E). Finally, we analyzed in early neurula embryos the
expression of Xnot that was reported to be localized to the
developing notochord by the end of gastrulation (von
Dassow et al., 1993). While expression of Xnot is detected
in the notochord in early neurula control embryos, its
expression is observed in the dorsal blastopore lip in
X-PAK5 K/R-injected embryos at equivalent developmental
stage, indicating that the dorsal mesoderm failed to involute
and notochord was not elongated in these embryos (Fig.
3F). Altogether, our results indicate that interfering with
X-PAK5 signaling in the DMZ modifies the behavior of
cells that undergo CE movement.
Rescue of X-PAK5 K/R phenotype by expression of X-PAK5
catalytic activity
We showed that X-PAK5 K/R impedes CE movements
during gastrulation. This suggests that the kinase activity
of X-PAK5 may be required for CE movements to occur.
In order to confirm this hypothesis, we supplemented
embryos with exogenous kinase activity by injecting various
amounts of mRNA coding for constitutively active X-PAK5
(X-PAK5/EN) (Cau et al., 2001). When injected at high
doses (N500 pg mRNAs per embryo) in the DMZ of
embryos at four-cell stage, the majority of expressingEmbryos were injected at four-cell stage in DMZ with either 300 pg of gfp
development. (A) Representative sample of (a) GFP-injected control (Ctrl)
ent. These embryos exhibit a shortened bent anteroposterior axis. In the most
. Note that GFP-X-PAK5 K/R-injected embryos have a fully formed head.
. Anti-X-PAK5 Western blot analyses of extracts from gfp control (Ctrl) and
rotein migrates around 80 kDa (see black arrowhead) whereas GFP-X-PAK5
le of embryos examined during gastrula and neurula stages. (a, c, e, and g)
a and b) stage 11, (c and d) stage 12, (e and f) stage 18, and (g and h) stage
at has not been internalized during gastrula. (i–l) Lineage tracer analyses of
embryos using gfp-emitted fluorescence. (i) GFP control (Ctrl) embryo at
ovements of injected cells are impaired. (k) GFP control (Ctrl) embryo at
ermal cells did not involute. Anterior (A) and posterior (P) regions of the
re injected in the animal pole either with gfp mRNA (300 pg per embryo) or
ised at stage 8.5 and incubated in the presence (+activin) or the absence
from gfp-injected control (Ctrl) embryos elongate while expression of
Fig. 3. X-PAK5 K/R expression affects the localization of mesodermal markers. Four-cell stage embryos were injected either with 300 pg of gfp mRNA or with
300 pg of GFP-X-PAK5 K/R mRNA in the DMZ and fixed at the indicated time. Expression of mesodermal genes was analyzed by in situ hybridization.
Expressions in gfp control (Ctrl) and GFP-X-PAK5 K/R-injected embryos are compared in each panel. (A) Expression of Brachury (Xbra) at stage 10+. (B)
Expression of gooscoid at stage 10+. (C) Expression of Brachury (Xbra) at stage 11.5. Note that Xbra expression in GFP-X-PAK5 K/R embryos is reduced in
the notochordal mesoderm (as indicated by black arrow) indicating that in GFP-X-PAK5 K/R-injected embryos, the dorsal mesoderm failed to involute during
gastrulation. (D) Expression of Xgsc at stage 12. Black arrows indicate the two domains of Xgsc expression in GFP-X-PAK5 K/R-injected embryos. (E)
Expression of Xotx-2 at stage 12.5. Black arrows indicate Xotx-2 staining in the blastopore lip in X-PAK5-KR-expressing embryos. (F) Expression of Xnot at
early neurula stage. In gfp control (Ctrl) embryos, Xnot expression is localized in the notochordal mesoderm whereas its expression is localized in the dorsal
blastopore lip in GFP-X-PAK5 K/R-injected embryos, indicating that the notochord was not elongated in GFP-X-PAK5 K/R-injected embryos.
S. Faure et al. / Developmental Biology 277 (2005) 472–492480embryos does not survive beyond stage 10 (data not shown).
At lower doses (100–400 pg mRNAs per embryo), all X-
PAK5/EN-injected embryos develop lesions around the
injection site in the DMZ that affects CE movements during
gastrulation in a dose-dependant manner (data not shown).
This result indicates that both gain and loss of X-PAK5
function affect CE movements at gastrula. Thus, a tight
balance is likely required between active and inactive states
in order to regulate CE movements. We thus examined
whether the effect of X-PAK5 K/R expression on CE could
be rescued by X-PAK5/EN. Because of the high activity of
X-PAK5/EN, we first injected different amounts of its
mRNA in the DMZ of embryos at four-cell stage in order to
establish the minimal activity that would not be deleterious
for CE movements (data not shown). Then, we injected
this amount of mRNA alone or in combination with X-
PAK5 K/R mRNA. We examined both the closure of the
blastopore at the end of gastrulation (stage 12) and the late
phenotypes (stage 28) of injected and co-injected embryos.
In the representative experiment described in Fig. 4 (see also
Table 2), X-PAK5 K/R expression (300 pg mRNA per
embryo) strongly delays blastopore closure at gastrulation in
74% (n = 80) (Fig. 4B), and 62% (n = 80) of the tadpoleembryos develop with a shortened anteroposterior axis and a
strong dorsal flexure (Fig. 4F). When injected alone (50 pg
mRNAs per embryo), X-PAK5/EN, as mentioned above,
had no significant effect on blastopore closure (Fig. 4C) and
embryos develop as gfp-injected controls (compare Figs. 4E
and 4G). However, injection of 50 pg of X-PAK5/EN
mRNA significantly rescues the delay in blastopore closure
induced by X-PAK5 K/R (Fig. 4D) and 70% (n = 72) of the
co-injected embryos develop as controls (Fig. 4H). In
conclusion, the kinase-dead X-PAK5 phenotype is rescued
by injection of X-PAK5/EN, indicating that a specific
amount of X-PAK5 catalytic activity is mandatory for CE
to occur.
X-PAK5/EN mutant affects the adhesive properties of
embryonic cells
We thus decided to further analyze how CE movements
are regulated by the catalytic activity of X-PAK5 kinase (Fig.
5). Microinjection in the animal hemisphere of X-PAK5/EN
mRNA induces defects not previously observed following
X-PAK5 K/R mutant expression. During early cleaving
stages, both gfp control and X-PAK5/EN-injected emQ
Fig. 4. Rescue of X-PAK5 K/R phenotype by expression of X-PAK5/EN.
Four-cell stage embryos were injected in the DMZ either with 300 pg of gfp
mRNA or with 300 pg of GFP-X-PAK5 K/R mRNA alone or in
combination with 50 pg GFP-X-PAK5/EN mRNA. Stage 12 equivalent
embryos (A, B, C, and D). (A) Gfp control (Ctrl) embryos, (B) GFP-X-
PAK5 K/R-injected embryos, (C) GFP-X-PAK5/EN-injected embryos,
and (D) GFP-X-PAK5 K/R and X-PAK5/EN co-injected embryos.
Expression of GFP-X-PAK5/EN efficiently rescues the delay in blasto-
pore closure induced by GFP-X-PAK5 K/R. Stage 28 equivalent embryos
(E, F, G, and H). (E) Gpf control (Ctrl) embryos, (F) GFP-X-PAK5 K/R-
injected embryos, (G) X-PAK5/EN-injected embryos, and (H) X-PAK5
K/R and X-PAK5/EN co-injected embryos. Expression of GFP-X-
PAK5/EN efficiently rescues the phenotype induced by GFP-X-PAK5
K/R as co-injected embryos develop normally or with a slight bent axis
as indicated by black arrow.
Table 2
Rescue of X-PAK5 K/R phenotypes by X-PAK5/EN
mRNA injected n Blastopore Late phenotypes
Normal Open Normal Shortened
axis
X-PAK5/EN 70 88 12 80 20
X-PAK5 K/R 80 26 74 38 62
X-PAK5 K/R +
X-PAK5/EN
72 80 20 70 30
Embryos were injected at four-cell stage in the DMZ with indicated
mRNAs. Blastopore closure and late phenotypes were scored at stage 12
and 28, respectively. Numbers refer to percentages of phenotypes, n refers
to the total number of embryos analyzed.
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morula to early blastula stages, those embryos develop
ectodermal lesions in a dose-dependant manner. Eighty
percent of embryos (n = 76) injected at two cell stage with
X-PAK5/EN mRNA (300 pg) present an abnormal
pigmentation around the injection site as indicated by
arrows in Fig. 5A (compare panels a–b to d–e). At these
early stages (6.5–8), prior to the early gastrula transition
checkpoint (EGT) when apoptosis is first detected (Howe
et al., 1995), we did not observe blastomere fragmentation
or embryo blebbing, as it was previously reported
following expression of the catalytic domain of subgroup
I X-PAK1 (Bisson et al., 2003). By gastrula (stage 10.25),
these embryos develop large ectodermal lesions (see arrow
in Fig. 5A, panel f), and we could visualize blebbing of
embryonic cells (data not shown), indicating that large
amounts of kinase activity are deleterious for embryos and
will eventually and consequently induce their death before
the end of gastrula.
Embryos injected with lower doses of mRNAs (38–150
pg per embryo) developed visible lesions on the animal pole
at late blastula/early gastrula stages (panels a–d in Fig. 5B).Analyses of animal caps dissected from control and
X-PAK5/EN-expressing embryos revealed that the latter
were hollowed compared to controls (as indicated by
black arrows in bV–dV in Fig. 5B), suggesting that most X-
PAK5/EN-expressing cells lost their adhesion to their
neighbors and dissociated from the remaining ectodermal
layer. Similar ectodermal lesions were previously reported
to be induced following expression of IQGAP1 and a E-
cadherin dominant-negative mutant that both affect cell
adhesion (Levine et al., 1994; Sokol et al., 2001). Loss of
cell adhesion induced by expression of X-PAK5/EN mutant
was confirmed by performing hemisections of whole
embryos expressing either the lineage tracer h-galactosidase
alone (control) or together with X-PAK5/EN mRNA. While
in control embryos, blue cells are tightly associated to the
ectodermal mass, X-PAK5/EN blue cells are loosely
associated; some of them dissociated from the roof of the
blastocoel and fall into the blastocoel cavity (see white
arrow in Fig. 5C, panel c). These results suggest that
expression of X-PAK5/EN decreases cell–cell adhesion. To
further confirm that X-PAK5 kinase activity regulates
adhesiveness between blastomeres, we first looked at cell
morphology in animal cap explants dissected from embryos
injected with either control gfp mRNA (gfp) or with GFP-
X-PAK5/EN mRNA (100 pg per embryo) by using a
confocal microscopic approach (Fig. 5D). Gfp control signal
is present in a diffuse state in the cytoplasm, faintly at
cellular junctions (Fig. 5D, Gfp), and in some nuclei (data
not shown). The GFP-X-PAK5/EN signal was essentially
diffuse in the cytoplasm and to some extent could be
observed in the vicinity of the cytoplasmic membrane.
Strikingly X-PAK5/EN-expressing cells appear very loosely
associated as depicted in the two images resulting from
consecutive 10-Am stacks (Fig. 5D, X-PAK5/EN). These
observations strengthen our previous results (Figs. 5A–C)
showing that, at the cellular level, catalytic X-PAK5 activity
induces a loss of adhesion between embryonic cells.
Loss of cell adhesion was previously shown to be
induced upon expression of Rac, Cdc42, and Rnd1 GTPases
(Choi and Han, 2002; Hens et al., 2002; Wunnenberg-
Stapleton et al., 1999). Loss of cell adhesion may also result
and thus be a consequence of apoptosis induction (Trindade
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adhesive properties, motility, and cell fate of prospective
head mesodermal cells are affected by blocking PDGFR
signaling during gastrulation (Ataliotis et al., 1995; Symes
and Mercola, 1996; Van Stry et al., 2004). Interfering with
this pathway induces gastrulation defects independent of CE
movements and accumulation of mesodermal cells in the
blastocoel cavity (Van Stry et al., 2004). These cells are
fated to die. However, rescue of apoptosis is not sufficient to
restore their motility, indicating that changes in motility andadhesive properties are not a consequence of apoptosis
induction. To discriminate between these regulations and
since both mammalian and Xenopus PAKs were shown to
regulate programmed cell death (Bokoch, 2003; Faure et al.,
1997), we investigated whether X-PAK5/EN may induce
apoptosis in early embryos. We assayed extracts of X-
PAK5/EN-injected embryos for caspase activity by testing
their ability to induce cleavage of the mammalian procas-
pase 3 (Fig. 5E). Such assay was previously developed in
Xenopus embryos using the caspase substrate poly(ADP)ri-
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Trindade et al., 2003). In cycloheximide-treated embryo
extracts, procaspase cleavage was induced, as visualized by
the appearance of proteolytic fragments of 20 and 16 kDa
(Fig. 5E, lane 2), but no cleavage was observed in control
embryo extracts (lane 1) and in X-PAK5/EN-injected
embryos (38–150 pg mRNA per embryo) (lanes 3–5). In
addition, expression of mRNA encoding for BCL-XL
together with various amounts of X-PAK5/EN mRNA did
not prevent the ability of X-PAK5/EN to induce ectodermal
lesions and deadhesion of cells, suggesting that, in X-PAK5/
EN-injected embryos (38–150 pg per embryo), the decrease
in cell–cell adhesion does not result from the induction of
the apoptotic program (data not shown). Since these loosely
associated cells were not programmed for death, we
analyzed what would be their fate in developing embryos.
Gfp (controls) or X-PAK5/EN-injected embryos (150 pg
mRNA per embryo) were kept growing up to stage 28 and
their morphology assessed by direct observation (Fig. 5F).
Around 40% of X-PAK5/EN-expressing embryos repeat-
edly developed very specific and homogenous defects
(panel b) compared to controls (panel a). Those defects
are characterized by the growth of tissue protruding from the
body axis of the embryo (panels b and c). Indeed, cells in
these tissues are gfp positive (Fig. 5E, see white arrows in
panel d), further proving that body extensions are derived
from cells that received the injected mRNA and that injected
cells are still alive at this stage of development. It is thus
likely that changes in adhesive properties of X-PAK5/EN-
expressing cells drive them in inappropriate locations where
they participate in the formation of protrusions. These
results further confirm that the level of X-PAK5 activity that
we expressed in embryos throughout this study does not
induce an apoptotic process, but rather a change in adhesive
behavior of the cells.Fig. 5. Expression of X-PAK5/EN induces ectodermal lesions when injected in th
either with gfp mRNA or with X-PAK5/EN mRNA (300 pg per embryo). (a–c)
PAK5/EN-injected embryos. (a and d) Stage 6.5, (b and e) stage 8, and (c and d) st
at the level of injection site (see arrows in d and e) and display large ectodermal les
of whole embryos and dissected animal caps following expression of various amo
embryos injected at two-cell stage in the animal pole with either 150 pg (b), 75 pg
animal caps were dissected at early gastrula stage. (aV–dV) Direct examination of co
in c (cV), and in d (dV). Black arrows in bV, cV, and dVindicate the position of the ecto
cells. Two-cell stage embryos were injected in the animal pole either with 200 pg o
EN mRNA. (a, b, and c) h-Gal-stained embryo sectioned at stage 10.25. Control
expressing h-galactosidase and GFP-X-PAK5/EN mRNAs (b and c). c represents
PAK5 mutants in embryonic cells. Embryos injected at two cell stage in the anima
mRNA (100 pg per embryos) were cultured until stage 8.5. Then, animal caps
analyzed with a confocal microscope LSM510. Images result from 10-Am stacks.
control-expressing cells. (E–F) X-PAK5/EN does not induce apoptosis. Embryos
(150 pg per embryo) or with various amounts of GFP-X-PAK5 E/N mRNA. (E) Pr
(lane 1), uninjected cycloheximide (CHX)-treated embryos (lane 2), or embryos in
X-PAK5/EN mRNA. Embryos were harvested at stage 13 and extracts were tested
procaspase 3. Only extracts from cycloheximide (CHX)-treated embryos induce pr
of 20 and 16 kDa). (F) Examination at late neurula stage of embryos expressing G
or embryos injected with GFP-X-PAK5/EN mRNA (b–d). c represents a higher m
the gfp signal emitted from the embryo shown in c. X-PAK5/EN gfp positive are
not die at the end of gastrulation. White arrows in c and d indicate the positionCalcium-dependant cell–cell adhesion is regulated by
X-PAK5
To further investigate whether the catalytic activity of X-
PAK5 regulates the adhesive properties of embryonic cells,
we performed an in vitro aggregation assay (Fig. 6). In this
assay, cells from animal explants were dissected at stage 8.5
from control or X-PAK5 mutant-injected embryos. Then,
cells were dissociated in Ca2+/Mg2+-free medium and
allowed to reaggregate by adding calcium back to the
medium. We first analyzed the effect of X-PAK5/EN
expression on dissociation and reassociation of cells (Fig.
6A). Cells from both gfp control and X-PAK5/EN-injected
cap explants were totally dissociated 60 min after calcium
withdrawal (Fig. 6A, calcium, 60 min). Control cells
reaggregated into tightly adherent structures (clumps) an
hour after supplementing medium with calcium (Fig. 6A,
+calcium, 60 min). In contrast, cells from X-PAK5/EN-
injected explants that dissociated more rapidly than control
cells (data not shown) either remain isolated or form small
loosely associated structures an hour after adding back
calcium to the medium (Fig. 6A, +calcium, 60 min). Thus,
expression of catalytically active X-PAK5 kinase decreases
calcium-dependent cell reaggregation.
We then studied the effect of X-PAK5 K/R expression
during the dissociation and reassociation procedure (Figs.
6B, 6C, and 6D). The properties of animal cap cells to
dissociate were again directly observed at the macroscopic
level and also at the microscopic level. For the latter, we
followed the gfp control or GFP-X-PAK5 K/R-expressing
cells using a confocal microscope. At the time dissections
were performed (calcium, 0 min), X-PAK5 K/R-express-
ing cells of the animal caps looked more tightly bound
than cells in control caps (Fig. 6B). At the onset of
dissociation in calcium-free medium (calcium, 5 min ande animal pole. (A) Two-cell stage embryos were injected in the animal pole
Examination of gfp control (Ctrl) embryos. (d–f) Examination of GFP-X
age 10.25. X-PAK5/EN-injected embryos exhibit an abnormal pigmentation
ions visible on the animal pole at gastrula (see arrow in f). (B) Examination
unts of GFP-X-PAK5/EN mRNA. Uninjected control (Ctrl) embryos (a) o
(c), or 38 pg (d) of GFP-X-PAK5/EN mRNAwere allowed to develop and
ntrol (Ctrl) animal caps (aV) or animal caps dissected from embryos in b (bV)
dermal lesions. (C) Lineage tracer analyses of GFP-X-PAK5/EN-expressing
f h-galactosidase mRNA alone or in combination with 200 pg of X-PAK5
(Ctrl) embryos expressing h-galactosidase mRNAs alone (a). Embryos co
a higher magnification of b inset. (D) Subcellular localization of GFP-X
l region with either gfp mRNA (200 pg per embryo) or GFP-X-PAK5 E/N
were dissected and gfp signal immediately (without fixation procedure
GFP-XPAK5/EN-expressing cells appear more loosely associated than gfp
were injected at two cell stage in the animal region with either gfp mRNA
ocaspase 3 cleavage assay on Xenopus embryos. Gfp control embryos (Ctrl
jected with either 150 pg (lane 3), 75 pg (lane 4), or 38 pg (lane 5) of GFP
for their ability to induce cleavage of (35S)methionine-labeled mammalian
ocaspase 3 cleavage (visualized by the appearance of proteolytic fragments
FP-X-PAK5/EN mRNA (150 pg injected per embryo). Gfp control (Ctrl) (a
agnification of X-PAK5/EN-expressing embryo. (d) Direct examination o
located in the protrusion, suggesting that X-PAK5/EN-mislocated cells did
of the gfp-positive protrusion on the embryo.-
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dissociation in X-PAK5 K/R-expressing animal cap
explants compared to gfp control explants, indicating that
X-PAK5 K/R-expressing cells might be more tightlyassociated than control cells. Eventually, both control and
X-PAK5 K/R-expressing caps were dissociated into single
cells after 2-h incubation in calcium-free medium (data not
shown).
Fig. 6. X-PAK5 catalytic activity regulates the adhesive properties of embryonic cells. (A) Aggregation assay. Two-cell stage embryos were injected in the
animal pole either with gfp mRNA (150 pg per embryo) or with GFP-X-PAK5/EN mRNA (150 pg per embryo). Then, animal regions were dissected at stage
8.5, incubated in Ca2+/Mg2+-free medium to allow complete dissociation of cells, and then reaggregated by adding back calcium to the medium. (A) Effect of
expression of GFP-X-PAK5/EN on dissociation (upper panel) and reaggregation (bottom panel) of cells. Gfp control cells (Ctrl) were totally dissociated after
1 h in Ca2+/Mg2+-free medium (calcium, 60 min). Their reassociation was visualized 1 h after calcium addition (+calcium, 60 min). GFP-X-PAK5/EN cells
were totally dissociated after 1 h in Ca2+/Mg2+-free medium (calcium, 60 min). However, GFP-X-PAK5/EN-expressing cells failed to reaggregate when
calcium was added back to the medium (+calcium, 60 min). (B) Effect of expression of GFP-X-PAK5 K/R on dissociation of cells. Two-cell stage embryos
were injected on the animal pole either with gfp mRNA (150 pg per embryo) or with GFP-X-PAK5/EN mRNA (150 pg per embryo). Gfp control (Ctrl) or
GFP-X-PAK5 K/R-injected animal explants were dissected in Ca2+/Mg2+-free medium and immediately harvested (calcium, 0 min) or harvested after 5 min
(calcium, 5 min) or 15 min (calcium, 15 min) incubation. GFP-X-PAK5 K/R expression delays dissociation of cells. (C–D) Subcellular localization of
GFP-X-PAK5 K/R mutant in animal cap explants. Embryos were injected at two cell stage with either gfp mRNA (200 pg per embryo) or GFP-X-PAK5 K/R
mRNA (250 pg per embryo). Animal caps were dissected at stage 8.5 and either directly examined for gfp signal on confocal microscope (C), or incubated in
Ca2+/Mg2+-free medium either for 2 min (Gfp, calcium, 2 min; GFP-X-PAK5 K/R, calcium, 2 min) or for 20 min (gfp, calcium, 20 min; X-PAK5/KR,
calcium, 20 min) (D). (E–F) Effect of expression of GFP-X-PAK5 K/R on reaggregation of cells. Gfp control (Ctrl) or GFP-X-PAK5 K/R-injected animal
caps were totally dissociated in Ca2+/Mg2+-free medium for 2 h. Then, calcium was added back to the medium and cells were harvested after either 2 min
(+calcium, 2 min), 5 min (+calcium, 5 min), or 15 min (+calcium, 15 min), and reaggregation of cells was examined. (F) Graph representing the relative
aggregation of animal cells after 15-min incubation with calcium in the representative experiment shown in D. The sizes of the clumps are indicated in legend
above the graph.
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Before calcium removal, gfp control signal was detected in
the nuclei and faintly at cellular junctions (Fig. 6C, Gfp),
while strikingly, signal from the gfp-X-PAK-K/R fusion
protein concentrated at cell junctions and stained to a lower
extent the cytoplasm (Fig. 6C, X-PAK5 K/R). These kinase-
dead mutant-expressing cells looked tightly associated. At
the onset of dissociation in Ca2+/Mg2+-free medium, animal
cap cells expressing gfp control became rounder and a
partial loss of adhesion between them was observed (Fig.
6D, Gfp, calcium, 2 min). These changes in cell shape and
cohesion greatly evolved during the 20-min incubation
period in calcium-free medium; by that time, most of the
cells were completely round and very loosely attached to
each other (Fig. 6D, Gfp, calcium 20 min). The gfp signal
appeared delocalized and concentrated to one region of
cells. In contrast, the general shape of animal caps
expressing GFP-X-PAK5 K/R was not affected after 2-min
incubation in Ca2+/Mg2+-free medium (Fig. 6D, X-PAK5
K/R, calcium 2 min) and the dead-kinase was still present
at cell junctions. After 20-min incubation without calcium,
GFP-X-PAK5 K/R to some extent still associated to cell–
cell junctions, although more cytoplasmic and even nuclearstaining of the dead kinase was observed at that time (Fig.
6D, X-PAK5-K/R, calcium, 20 min). We thus confirm that
dead-kinase expression delays the loss of adhesion between
embryonic cells that result from the absence of calcium in
the medium.
At the macroscopic level, expression of X-PAK5 K/R
interfered as well with the kinetics of calcium-dependent
cell reaggregation. Indeed, once totally dissociated, X-PAK5
K/R-expressing cells started to associate to each other as
soon as 5 min after calcium addition, whereas control cells
remained individualized (Fig. 6E, +calcium, 5 min). Later
during the reassociation process, clumps formed of X-PAK5
K/R-expressing cells were repeatedly larger than controls
clumps (Fig. 6E, X-PAK5-K/R, +calcium, 5 min; +calcium,
15 min; Fig. 6F). Taken together, our results show that
X-PAK5 catalytic activity regulates the adhesive properties
of embryonic cells in response to extracellular calcium.
Endogenous X-PAK5 activity is regulated in a
calcium-dependant manner
Our results indicate that keeping a constant level of X-
PAK5 activity in embryonic cells by expressing X-PAK5/
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embryos and prevents cell–cell reaggregation induced by
calcium in an aggregation assay (Figs. 5 and 6). If
endogenous X-PAK5 regulates in vivo calcium-dependent
cell–cell adhesion during early development, its activity
is likely to be finely regulated to allow reassociation of
cells. This hypothesis led us to measure the endogenous
X-PAK5 activity during the dissociation and reassociation
procedure in an aggregation assay (Fig. 7). Animal cap
explants from uninjected embryos were dissected at stage
8.5 in Ca2+/Mg2+-free medium and harvested immediately
after dissection (calcium, 0 min) or after incubation of 5
or 15 min (Fig. 7A). Once cells were totally dissociated
(calcium, 60 min), they were allowed to reaggregate by
adding calcium back to the medium (Fig. 7B). Both activity
and levels of endogenous X-PAK5 were analyzed during
the dissociation and reassociation procedure. Endogenous
X-PAK5 activity was measured by Western blot analyses
using anti-phosphoPAK5 antibodies. These antibodies were
made against a phosphopeptide located in the catalytic loop
of subgroup II PAKs and surrounding Ser533 in X-PAK5.
They specifically detect catalytically active X-PAK5 (see
also Materials and methods and Supplementary Fig. S1).
During the cells’ dissociation procedure (Fig. 7A), no
dramatic changes in X-PAK5 activity were observed using
anti-phosphoPAK5 antibodies, and X-PAK5 expression
level, as well as X-PAK2 and g-tubulin levels that serve
as loading controls, remained constant. However, a very
strong inhibition of endogenous kinase activity was
observed as soon as calcium was added back to the medium
(Fig. 7B). Downregulation of kinase activity was measured
5 min after addition of calcium and while cell aggregation
was not yet observed (Fig. 7C, +calcium, 5 min).Fig. 7. Endogenous X-PAK5 kinase activity is regulated by a calcium-dependen
medium and animal caps dissected and harvested either immediately after disse
(calcium, 5 min), 15 min (calcium, 15 min), or 60 min (calcium, 60 min) o
harvested during the reassociation procedure after 5 min (+calcium, 5 min), 15 m
calcium. (A) Dissociation procedure. (B) Reassociation procedure. In A and B, lys
blot analysis using anti-PhosphoPAK5 antibodies that specifically recognize ca
methods). In parallel, X-PAK5, X-PAK2, and g tubulin levels were analyzed by
shown in B.Inactivation of X-PAK5 was correlated with a delay in its
electrophoretic mobility that was analyzed in parallel by
Western blot. X-PAK2 and gtubulin levels analyzed in
parallel on the same Western blot insured that loading was
accurate and that X-PAK5 mobility shift upon calcium
addition was specific. We previously show that maintaining
a constant level of X-PAK5 activity in embryonic cells
prevents cell–cell reaggregation induced by calcium (Fig.
6A). Here, we show that inactivation of endogenous
X-PAK5 upon calcium addition precedes reaggregation of
cells. Altogether, our data suggest that inactivation of X-
PAK5 may be a prerequisite for reaggregation of cells in the
presence of calcium. During the course of the reassociation
procedure, we observed the reappearance of the phosphoX-
PAK5 signal, indicating that the kinase slowly got phos-
phorylated on residue serine 533 and thus reactivated once
cells began to reaggregate (Fig. 7B). Reappearance of the
phosphoX-PAK5 signal was correlated at 30 min by its
mobility on Western blot, mobility that tended to return to
normal (Fig. 7B, compare X-PAK5 and PX-PAK5 panels).
When CE movements occur, cells rapidly change
neighbors. This is likely accompanied by discrete and
localized changes in extracellular calcium concentration
that allow cells to intercalate between each other. In these
physiological conditions, individual cells must be in
different responsive state regarding adhesion/loss of
adhesion to their neighbors. We indeed could not mimic
such precise events to address the regulation of X-PAK5
catalytic activity upon changes in extracellular calcium.
Nonetheless, we show that in an assay in which all cells
are dissociated, the addition of exogenous calcium down-
regulates the endogenous X-PAK5 catalytic activity. This
result clearly indicates that endogenous X-PAK5 activityt event. Stage 8.5 uninjected embryos were transferred to Ca2+/Mg2+-free
ction (calcium, 0 min) or during the dissociation procedure after 5 min
f incubation. Then calcium was added back to the medium and cells were
in (+calcium, 15 min), or 30 min (+calcium, 30 min) of incubation with
ates of explants were analyzed for endogenous X-PAK5 activity by Western
talytically active Ser533-phosphorylated X-PAK5 (also see Materials and
Western blot. (C) Examination of cells during the reassociation procedure
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switches that embryonic cells must undergo during CE
movements.
X-PAK5 is located at cell–cell junctions and partially
colocalizes with adherens junction proteins
We showed that the catalytic activity of X-PAK5
regulates adhesion between cells (Figs. 5 and 6) and that
endogenous X-PAK5 activity is downregulated by calcium
during the reassociation procedure (Fig. 7B). Cadherins are
major transmembrane proteins that are complexed with
catenins and mediate calcium dependent cell–cell adhesion
(for review, see Gumbiner, 2000). We thus decided to
examine whether endogenous X-PAK5 and overexpressed
mutants may colocalize with known adherens junctions
proteins. We used A6 epithelial cells that were either mock
transfected and stained for endogenous PAK5 or trans-
fected by GFP-X-PAK5-K/R or GFP-X-PAK5/EN. All
cells were immunostained with either g catenin or E-
cadherin antibodies (Fig. 8). In almost confluent mono-
layers, endogenous X-PAK5 is present both in a punctate
pattern in the cytoplasm and at cell–cell junctions where it
colocalizes with both E-cadherin and g-catenin (upper
panel in Fig. 8). However, colocalization at cell junctions
is not total, suggesting that protein recruitment at the
junction may be regulated. In X-PAK5-K/R-expressing
cells (medium panel), the gfp signal detected shows that
the kinase strongly associates to modified microtubules as
previously reported (Cau et al., 2001), but stains as well
the cytoplasmic membrane where it colocalizes at cellFig. 8. Localization of endogenous X-PAK5, X-PAK5K/R, and X-PAK5/EN mut
mock, GFP-X-PAK5/KR, or GFP-X-PAK5 E/N transfected for 24 h. Colocalizatio
cadherin was performed.junctions with both g-catenin and E-cadherin (see arrows).
Cells expressing active kinase (X-PAK5/EN, bottom panel)
have a very altered morphology (Cau et al., 2001)
presenting long cytoplasmic extensions and are growing
above the cell monolayer (as seen with Z projection on
confocal microscope, data not shown). In these cells, E-
cadherin is still present at the plasma membrane and also
in the cytoplasm. The gfp signal detected shows that the
active kinase is essentially diffuse in the cytoplasm and
does neither appear enriched at the cytoplasmic membrane
nor colocalized with E-cadherin. However, in cells
expressing lower levels of active kinase that are still part
of the monolayer, colocalization between X-PAK5/EN and
E-cadherin was often observed (data not shown). Such
colocalization is also observed with g-catenin (X-PAK5/
EN and g-catenin panels) where the end of processes in
expressing cells that contact cells in the monolayer are
costained with both X-PAK5/EN and g-catenin (see
arrows). In summary, localizations of the endogenous X-
PAK5 and the dead and active exogenous mutants are
consistent with X-PAK5 function in regulating adhesion
between cells.Discussion
The formation and elongation of the embryonic body
axis during Xenopus gastrulation are triggered by cellular
rearrangements commonly termed convergent extension
(CE) (Wallingford et al., 2002). CE movements are
accompanied by changes in shape, polarity, and adhesiveant epithelial A6 Xenopus cells. Almost confluent A6 epithelial cells were
n of the endogenous X-PAK5, dead, and active kinase with g-catenin and E-
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marginal zone elongate and extend mediolaterally polarized
filopodia and lamellipodia; these protrusions make stable
contacts with neighboring cells and exert traction permitting
cells to intercalate (Keller et al., 2000; Shih and Keller,
1992; Tahinci and Symes, 2003). Although the morpho-
logical details of CE movements during gastrulation in
Xenopus embryos are well characterized, the molecular
basis of these cell rearrangements remains to be clarified.
PAKs are multifunctional kinases that play key functions
in cell cytoskeleton rearrangement, polarization, and migra-
tion (for review, see Bokoch, 2003; Jaffer and Chernoff,
2002). We previously reported the identification of X-
PAK5, a Xenopus PAK protein that is involved in the
regulation of cytoskeleton organization (Cau et al., 2001).
Indeed, in cell culture ,the kinase-dead mutant stabilizes a
subset of MTs, while active kinase induces major cell shape
changes, characterized by cytoplasmic processes that are
decorated by filopodia (Cau et al., 2001). These properties
led us to investigate the putative roles of X-PAK5 in
Xenopus embryo morphogenesis.
X-PAK5 activity regulates adhesion between cells during
CE movements
In this study, we show that X-PAK5 may play an
important role in regulating Xenopus morphogenesis
through its ability to modulate cell adhesive properties.
First, X-PAK5 is expressed in tissues undergoing extensive
morphogenetic movements at gastrula such as the ectoderm
and the involuting mesoderm (Fig. 1). Similar spatial
distribution was reported for genes whose roles have been
suggested in morphogenesis. Most of these genes encode
either for cell adhesion molecules such as cadherins (Costa
et al., 1998; Kuhl et al., 1996; Lee and Gumbiner, 1995;
Levine et al., 1994), integrins (Ramos et al., 1996), and
protocadherins (Bradley et al., 1998; Kim et al., 1998), or
for proteins that regulate cell adhesion including small Rho-
like GTPase XRnd1 (Wunnenberg-Stapleton et al., 1999),
XRac, and XCdc42 (Choi and Han, 2002; Lucas et al.,
2002) that bind both X-PAK5 (Cau et al., 2001) and
components of the noncanonical Wnt signaling pathway
such as XWnt-5a (Moon et al., 1993) and XFz7 (Djiane et
al., 2000). Second, expression of X-PAK5 kinase activity in
developing embryos causes a dramatic loss of cell adhesion
(Figs. 5A–D) while embryonic cells expressing the dead
kinase are tightly associated together. The dead kinase being
sharply localized at the cells boundaries (Fig. 6C). These
results indeed suggest that X-PAK5 activity may be
involved in regulating cell–cell adhesion. Third, the
endogenous X-PAK5 is localized at the adherence junctions
in animal cap cells and in DMZ cells (Fig. 1D). Fourth,
endogenous kinase activity (Fig. 7) and localization (not
shown) are not modified upon embryonic cell dissociation
by calcium removal. However, its activity is downregulated
when calcium is added to the medium. X-PAK5 inactivationoccurs before newly formed junctions between cells become
visible (data not shown), indicating that downregulation of
kinase activity may be required for the establishment of new
junctions. This regulation likely represents a transient
response of the kinase to calcium since once cell junctions
clearly form, the kinase slowly got reactivated. This is
confirmed by an assay showing that calcium addition to
dissociated cells is no longer efficient to induce adhesion of
cells when X-PAK5 is kept catalytically active while
adhesion is facilitated in cells expressing the dead kinase
mutant (Figs. 6E–F). Moreover, dead kinase (KR mutant)
expression in embryonic cells delays their dissociation when
calcium is removed from the extracellular medium (Figs. 6B
and D). Thus, X-PAK5 may regulate adhesion between cells
by interfering with the calcium response.
Finally, expression of a kinase-dead mutant of X-PAK5
inhibits dorsal cell intercalation during CE movements in
whole embryos and in activin-treated animal cap explants
without affecting mesodermal specification (Figs. 2 and 3).
The involution of marginal zone cells during gastrula
requires the loosening and rearrangements of cell–cell
contacts (Wilson and Keller, 1991). In embryos expressing
X-PAK5/EN in the DMZ, CE movements are impaired as a
consequence of cell dissociation. We speculate that, in X-
PAK5 K/R-expressing embryos, the adhesiveness of
expressing cells is too strong and prevents the dynamic cell
rearrangements necessary for CE. Thus, a very tight balance
is likely to exist between activation/inactivation of the X-
PAK5 catalytic activity in order to regulate CE.
At this point it is tempting to speculate that activation/
inactivation switches of X-PAK5 may be regulated by the
intercellular waves of calcium that were previously described
in tissues undergoing CE (Gilland et al., 1999; Leclerc et al.,
2000). More specifically, in Xenopus DMZ explants,
transient calcium waves are required for CE movements to
occur (Wallingford et al., 2001) and the authors proposed
they may represent a general mechanism to coordinate CE.
The relationship between X-PAK5 and these intercellular
calcium waves would indeed be an interesting issue to
address in the future. Taken altogether, our results suggest
that the function of X-PAK5 in the embryo is to regulate
adhesion of cells that are undergoing morphogenetic move-
ments under intercellular calcium signaling.
PAKs also play active functions during epithelial cell
colony spreading and dissociation in response to HGF
(Royal et al., 2000), a model that implies as well deadhesion
and dissociation of cells before motility can occur. Finally,
hPAK4, another subgroup II PAK member, alters cell
adhesion and increases invasiveness potential (Qu et al.,
2001). We cannot rule out in our study that X-PAK5/EN and
X-PAK5K/R may interfere with the activity of another PAK
family member. This hypothesis remains, however, unlikely
since endogenous X-PAK5 is present at cell junctions as
well and is regulated when dissociated embryonic cells from
cap explant are allowed to associate by calcium addition.
Indeed, other members of the Xenopus PAK gene family are
S. Faure et al. / Developmental Biology 277 (2005) 472–492 489expressed during development but their patterns are clearly
distinct from that of X-PAK5 (Islam et al., 2000; Souopgui
et al., 2002) and neither X-PAK1 nor X-PAK3 appears to
regulate cell adhesion (Bisson et al., 2003; Souopgui et al.,
2002).
Loss of adhesion between cells is sometimes a conse-
quence of induced apoptosis, and PAK members play active
functions in regulating (both positively and negatively) the
apoptosis pathway. For example, X-PAK1 has protective
function against apoptosis in Xenopus egg extracts (Faure et
al., 1997) while its activation by proteolytic cleavage is
sufficient for apoptotic body formation during Xenopus
early development (Bisson et al., 2003). Although the
lesions we observed with expression of active X-PAK5
mutant were clearly different than X-PAK1-induced lesions
(Bisson et al., 2003), we studied the fate of active kinase-
expressing cells to eliminate the hypothesis that control of
cell–cell adhesion by PAK5 was a mere consequence of
apoptosis induction. Tadpole-expressing active X-PAK5
does not die, nor the X-PAK5 expressing cells that also
multiply and form tissue protrusion on tadpole bodies.
These protrusions likely emanate from cells that lost their
adhesion and fall on the floor of the blastocoel.
Which factors regulate X-PAK5 activity?
During CE movements, rapid changes are likely to be
required at cell/cell junctions to remodel the adhesive
contacts that must break and form again (Gumbiner, 2000)
and to regulate protrusive activity. We hypothesize that a
switch between activation/inactivation of the X-PAK5
catalytic activity may participate to such regulation.
The small GTPase Cdc42 regulates Ca2+-dependent cell
adhesion in Xenopus embryonic cells. IQGAP1, a Cdc42
effector, regulates cell adhesion in response to calcium and
induces similar ectodermic lesions than X-PAK5 during
early development (Sokol et al., 2001). In addition, Rac,
RhoA, and XRnd1 GTPases are also reported to regulate
cell adhesion in the ectoderm (Hens et al., 2002; Wunnen-
berg-Stapleton et al., 1999). During CE, protrusive activity
is at least modulated by Rac and RhoA GTPases (Tahinci
and Symes, 2003). They regulate lamellipodia and filopodia
formation (rac-dependent), polarization of the protrusive
activity (Rac and Rho-dependent) and cell shape (Rho-
dependent) (Tahinci and Symes, 2003). Such a study on
Cdc42 functional importance in regulating protrusive
activity during CE is still lacking and would be of interest.
Active X-PAK5 promotes filopodia in cell culture (Cau et
al., 2001), and we did observe that expression of low
X-PAK5 activity in animal cap explant cells induced a
protrusive activity mainly characterized by filopodia (data
not shown). In the future, these observations indeed will
require to be more documented by dynamic studies in
gastrula embryos. Thus, X-PAK5 activity may be regulated
by one these GTPases or a yet nonidentified member of this
family. However, X-PAK5 binding both to Rac or Cdc42GTPases does not allow its catalytic activation (Cau et al.,
2001), a common feature to subgroup II PAK members.
Therefore, alternate pathways that involve complex recruit-
ment to the plasma membrane as recently described for
subgroup I PAK should also be considered (Li et al., 2003).
We present preliminary data in Fig. 8 that show
endogenous X-PAK5 and the kinase active and kinase dead
ectopic X-PAK5 colocalization with the two adherens
junction proteins E-cadherin and g-catenin. Endogenous
kinase partial colocalizations with E-cadherin and g-catenin
indicate that its association to cell–cell junctions may be
regulated. Both mutants also share some colocalization with
these two markers. Indeed, more partners of the adherens
junctions should be studied for their colocalization with
endogenous X-PAK5 and their putative mislocalization
under the expression of active and dead PAK5 kinase
mutants (see below). This work is currently under develop-
ment in the laboratory.
It is tempting to speculate that X-PAK5 activation/
inactivation switch may control the assembly of a mem-
brane-bound complex that would form at cell–cell junctions
and control adhesion. In such complex, partners would
likely evolve after modification (i.e., phosphorylation).
Cadherins are key components of adherence junctions (for
review, see Aplin et al., 1999). Many other proteins such as
Dishevelled, PKC, Rho, Rac, Cdc42 and IQGAP, p120
catenin, and a-catenin are also located at cell junctions and
could potentially regulate X-PAK5 activity. IQGAP asso-
ciates with filopodia in Xenopus cells (Yamashiro et al.,
2003) and induces their formation (Swart-Mataraza et al.,
2002). Translocation of IQGAP1 to cell–cell contacts
disrupts cadherin-catenin complexes and decreases cell–cell
adhesion (Kuroda et al., 1998; Li et al., 1999). IQGAP1-
induced lesions in the ectoderm of Xenopus embryo depend
upon its capacity to bind Cdc42, although the latter is not
sufficient to confer that phenotype (Sokol et al., 2001),
suggesting that another factor is required. In that regard, it
will be of specific interest in the future to study whether
PAK5 may participate to IQGAP1-induced phenotype in
adhesion or if Cdc42-bound IQGAP1 may modulate X-
PAK5 activity.
We speculate that p120 catenin, a cadherin binding
protein and a member of the armadillo protein family, could
be another putative target for X-PAK5 kinase. Indeed, p120
catenin mutants regulate cell adhesion and can activate Rac
and Cdc42 GTPases (for review, see Gumbiner, 2000). The
p120 catenin protein was recently shown to bind micro-
tubules and promote the traffic of cadherin to the cell
surface (Chen et al., 2003). Interestingly, mutation of serine
residues to alanine in the Arm repeat of p120 catenin
promotes its association with interphase microtubules
(Franz and Ridley, 2004). These interphase microtubules
are stabilized and look like X-PAK5K/R-induced stable
microtubules. Moreover, the wild-type p120 catenin induces
a dendritic morphology that resembles much of X-PAK5/
EN-induced changes in cell morphology. Relationships
S. Faure et al. / Developmental Biology 277 (2005) 472–492490between X-PAK5 and p120 catenin represent an interesting
issue to study in the future.
In conclusion, this study identifies X-PAK5 as a new
regulator of CE movements during gastrulation. Future
studies to address the mechanism by which X-PAK5
regulates CE movements will include the examination of
its function in recruitment or phosphorylation of other cell
junction proteins at the plasma membrane.Acknowledgments
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